Roka Bioscience
Warren
About Roka Bioscience
Roka Bioscience is dedicated to developing rapid, highly accurate molecular assays and instrument systems for the Food Safety Industry. Its newly released Atlas System represents a new tier of molecular rapid pathogen testing, offering automation and technology that bring true walk-away convenience and workflow advantages to the laboratory. Roka is focused on creating novel testing solutions that help manufacturers mitigate risks, protect their brands, and meet the increasing testing demands now and for years to come.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Delisted
- Employees: 51 – 100
- Estimated revenue: $100K – $500K
- Total funding: $132.0M
- Funding stage: IPO
- Last round: Post-IPO Equity (Sep 2016)
- Ticker: nasdaq:ROKA
- Website: rokabio.com
- Phone: 9086054707
Industries & Categories
Biotechnology, Food and Beverage, Health Care
Social Profiles
Canonical: https://fsome.com/organization/roka-bioscience-173426 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.